BioSpace News Archive

Livanta LLC was honored with a Spotlight Award from the Centers for Medicare & Medicaid Services (CMS) for The Livanta Compass e-newsletter. The weekly publication was recognized as an effective communication vehicle for reaching rural communities to build awareness of Livanta’s activities as a Medicare Beneficiary and Family Centered Care Quality Improvement Organization (BFCC-QIO). The inaugural Spotlight Awards were presented

INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world’s only in vivo Intravaginal Culture System, announced today that it will effect a 1-for-20 reverse stock split, previously approved by the Company’s Boa

PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) is pleased to announce that it has received its NPN (Natural Product Number) from Health Canada. Primo Nutraceuticals hand sanitizers meet Health Canada’s requirements for safety, effectiveness and quality.

Abacus Health Products, Inc. (CSE: ABCS, OTCQB: ABAHF) (“Abacus” or the “Company”) announces that it will release its 2020 first quarter financial results on Thursday, May 28, 2020, prior to the market open. The Company will not be hosting a conference call to discuss the results. The Company intends to hold the previously-announced special shareholders meeting (“Meeting”) on Thursday, June 4, 2020 at

Nektar Therapeutics (Nasdaq: NKTR) today announced the publication of Phase 1 clinical data for its lead immuno-oncology candidate, bempegaldesleukin (BEMPEG: NKTR-214) in combination with nivolumab, in Cancer Discovery, a journal of the American Association for Cancer Research. Previously published Phase 1 data in Cancer Discovery o

MedX Health Corp. (“MedX”) (TSX-V: MDX) is pleased to announce the appointment of healthcare industry executive Damon Goodwin as Global Director of Sales, effective immediately. Mr. Goodwin will play an integral part in MedX’s revenue growth by building global partnerships for MedX’s skin assessment telemedicine technology. Initially supporting the roll out and expansions in Mexico, Brazil and the USA, he will also b

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval for the Android™ version of its Guardian™ Connect continuous glucose monitoring (CGM) system.

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has added leading network marketer Daniele Paiola Bellucci to

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that their COVID-19 vaccine program has reached a milestone with the manufacturing of 33 Ii-Key-SARS-CoV-2 peptides using antigenic epitopes predicted by computational vaccinology algorithms.

Ten new Ohio schools received STEM/STEAM School Designation. The Ohio STEM Committee approved applications for schools that implement best practices in STEM and STEAM education.